WHO rules require manufacturers to put into practice a constant risk management system for sterility test isolators, like typical hazard assessments and the development of possibility-primarily based Regulate techniques. Manufacturers looking to employ these approaches ought to offer robust validation details to show their equivalence to pharmacopoeial methods. By waiting for link from Forum Profiles (11)